Recent Finacing
Recent Raise
Durin Technologies develops non-invasive, easy-access Duritect assays for rapid, high-accuracy detection and monitoring of neurodegenerative diseases, with Alzheimer’s and Parkinson’s tests slated for 2024 commercialization.